Systematic Naming Tools Deployed throughout Incyte via ACD/I-Lab: Intranet Edition
Toronto, Canada, January 12, 2004 –
Advanced Chemistry Development, Inc., (ACD/Labs) has successfully deployed their systematic naming tools throughout Incyte Corporation via their Interactive Laboratory tool, ACD/I-Lab.
ACD/I-Lab: Intranet Edition is the server-based chemical prediction and search technology that enables users within an organization to access the latest chemical databases and property prediction programs through their corporate intranet while eliminating the need to deploy desktop software on each machine.
Through integration between ACD/Labs and Synthematix®, Inc., users of Synthematix’s Arthur™ Suite reaction planning system are able to access selected ACD/I-Lab tools from within the Arthur synthetic chemistry environment. Arthur users can add the ability to predict the physicochemical properties of their molecular structures, predict the multinuclear NMR spectra of their reaction products, and generate chemical names, based on either IUPAC or CAS Index rules, to populate their structure databases with systematic nomenclature.
Incyte recently licensed Arthur Suite for their own medicinal chemists, as it offered the right mix of functionality and ease-of-use to help increase the efficiency and effectiveness of their drug discovery efforts. When it came time for Incyte to purchase a naming solution for their enterprise, ACD/I-Lab’s naming tools were the natural fit, as they offered not only the industry standard in naming capabilities, but a solution that could be fully integrated with their existing system.
Brian Metcalf, Ph.D., Executive Vice President and Chief Drug Discovery Scientist at Incyte, stated, “The integrated ACD/I-Lab naming tool allows our medicinal chemists to quickly and accurately generate IUPAC names within the Synthematix e-notebook for the reagents and compounds synthesized in our labs. We expect the ACD/I-Lab naming tool will increase the efficiency of our chemistry efforts.”
Antony Williams, Ph.D., V.P. Scientific Development and Marketing at ACD/Labs, adds, “ACD/Name is the quality standard in systematic nomenclature software. Deploying these algorithms via our ACD/I-Lab technology, and integrating to the Arthur Suite, offers chemists at Incyte seamless access to the industry standard naming software in a web-based environment. We are confident that Incyte chemists will truly benefit from the fruits of our collaboration.”
About Advanced Chemistry Development
Advanced Chemistry Development, Inc., (ACD/Labs) is a chemistry software company offering solutions that truly integrate chemical structures with analytical chemistry information to produce ChemAnalytics™. ACD/Labs creates innovative software packages that aid chemical research scientists worldwide with spectroscopic validation of structures, elucidation of unknown substances, chromatographic separation, medicinal chemistry, preformulation of novel drug agents, systematic nomenclature generation, and chemical patenting and publication. Combined, ACD/Labs’ solutions create an analytical informatics system that provides dramatic feed-forward effects on the chemical and pharmaceutical research process. Founded in 1993, and headquartered in Toronto, Canada, ACD/Labs employs a team of over 100 dedicated individuals whose continual efforts carry ACD/Labs’ innovative technologies into pharmaceutical, biotech, chemical, and materials companies throughout the world. Information about Advanced Chemistry Development and its products can be found at www.acdlabs.com.
About Incyte Corporation
Incyte is a drug discovery company that discovers and develops novel therapeutics, and markets and licenses genomic information. It has three internal discovery programs focused on new small molecule drugs for cancer and inflammation, and one experimental drug in Phase II clinical development to treat HIV. Incyte markets and licenses genomic and proteomic information and intellectual property to many of the world’s leading pharmaceutical and biotechnology companies and academic research centers to help them create novel, more effective therapies and diagnostics. Incyte has offices in Palo Alto, California; Wilmington, Delaware; Beverly, Massachusetts; Cambridge, UK and Tokyo, Japan. For more information, please visit Incyte’s website at www.incyte.com.
About Synthematix
Synthematix, Inc., based in Research Triangle Park, NC, provides software for creating Comprehensive Chemistry Workflow Environments for synthetic chemists. Synthematix’s products consist of the Arthur™ Suite of software and informatics products as well as the Synthematix SubstructureSearch™ technology. These products allow chemists to build, access and mine chemical databases with unprecedented power and flexibility. ARTHUR™ users include Cubist Pharmaceuticals, Incyte Corporation, Inspire Pharmaceuticals, Plexxikon Corporation, Sigma Aldrich and other leading chemistry organizations. These tools and databases increase the effectiveness and efficiency of research chemists while permitting enhanced access to a company’s chemical R&D assets. Please visit www.synthematix.com for more information.
